Gene · 3021
NIH grants1,242
NIH grants whose papers are about the gene, through NIH's grant-paper links.
461 to 480 of 1,242
Download this page as JSON| Grant | Title | H3-3B papers | Newest fiscal year |
|---|---|---|---|
| ZICDK015500 | Production and purification of biological compounds | 1 | 2022 |
| P50MH096890 | Epigenetic Mechanisms of Depression | 8 | 2021 |
| DP1DA042078 | Roles for histone monoaminylation in cocaine-induced transcriptional and behavioral plasticity | 4 | 2021 |
| R01AR049069 | Molecular Control of Bone Formation | 4 | 2021 |
| R37GM086868 | Structure, Function and Applications of Inteins | 4 | 2021 |
| R01CA154683 | Deciphering the tumor suppressive functions of macroH2A | 3 | 2021 |
| R35GM124736 | Molecular mechanisms of chromatin and epigenetic regulation | 3 | 2021 |
| T32CA115299 | Training in Tumor Virology | 3 | 2021 |
| K08AI128043 | Role of virus-receptor interactions in determining norovirus tropism and pathogenesis in vivo | 2 | 2021 |
| R01CA204297 | The epigenetic mechanisms of high-grade pediatric glioblastoma | 2 | 2021 |
| R01DK118266 | Biochemistry of the lysine beta-hydroxybutyrylation pathway | 2 | 2021 |
| R01GM074233 | Chromatin Transitions during Early Embryonic Development in Drosophila melanogaster | 2 | 2021 |
| R01NS079697 | Tumor cell and microenvironment changes causing antiangiogenic therapy resistance | 2 | 2021 |
| R37NS094804 | Immune-suppressive Myeloid Cells in the Glioma Microenvironment: Signaling Mechanisms and Novel Therapeutic Strategies | 2 | 2021 |
| DP1AG058605 | Uncovering the Human Secretome | 1 | 2021 |
| F30CA247447 | Determining the function and mechanism of the MALAT1 long non-coding RNA in co-transcriptional splicing | 1 | 2021 |
| F30HL136080 | Long Non-Coding RNA-mediated Differential Regulation of Notch Pathway Targets in Early T-cell Development | 1 | 2021 |
| F31AG069456 | Alzheimer's Disease Characterization via a Novel Native Mass Spectrometry Platform | 1 | 2021 |
| F31NS110206 | Non-cell autonomous mechanisms of neural circuit wiring mediated by chromatin regulation | 1 | 2021 |
| F32AA028148 | Transcriptome-guided diagnosis and therapy for alcohol use disorder | 1 | 2021 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3021/grants?page=24